Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2011-06-08

Clinical Trial Update: Study to Test the Effectiveness of a New Treatment for Scalp Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial for psoriasis sponsored by DermiPsor, Ltd. is suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Investigational therapy (NCT01368887)

Snippet

Sponsor: DermiPsor, Ltd. | Conditions: Psoriasis | Phase 2 | Status: SUSPENDED